Sartorius Aktiengesellschaft (SRT3.DE)
EUR 209.0
(-2.34%)
EUR 209.0
(-2.34%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 543.2 Million EUR | -55.91% |
| 2022 | 1.13 Billion EUR | 54.38% |
| 2021 | 735.79 Million EUR | 40.56% |
| 2020 | 523.47 Million EUR | 47.06% |
| 2019 | 355.94 Million EUR | 18.4% |
| 2018 | 300.62 Million EUR | 14.32% |
| 2017 | 262.96 Million EUR | 6.17% |
| 2016 | 247.66 Million EUR | 17.02% |
| 2015 | 211.65 Million EUR | 62.63% |
| 2014 | 130.14 Million EUR | 4.72% |
| 2013 | 124.27 Million EUR | -0.95% |
| 2012 | 125.47 Million EUR | 34.7% |
| 2011 | 93.14 Million EUR | 20.84% |
| 2010 | 77.08 Million EUR | 222.72% |
| 2009 | 23.88 Million EUR | -57.97% |
| 2008 | 56.83 Million EUR | 15.21% |
| 2007 | 49.33 Million EUR | -8.9% |
| 2006 | 54.15 Million EUR | 24.06% |
| 2005 | 43.65 Million EUR | 34.28% |
| 2004 | 32.5 Million EUR | 121.47% |
| 2003 | 14.67 Million EUR | 8.56% |
| 2002 | 13.52 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 143.8 Million EUR | 115.27% |
| 2024 Q2 | 148 Million EUR | 2.92% |
| 2024 Q3 | 68.2 Million EUR | -53.92% |
| 2023 Q2 | 207.3 Million EUR | 4.64% |
| 2023 Q4 | 66.8 Million EUR | -16.5% |
| 2023 Q1 | 198.1 Million EUR | -2.32% |
| 2023 Q3 | 80 Million EUR | -61.41% |
| 2023 FY | 500.8 Million EUR | -55.91% |
| 2022 Q3 | 319.9 Million EUR | -1.45% |
| 2022 Q4 | 202.8 Million EUR | -36.61% |
| 2022 FY | 1.13 Billion EUR | 54.38% |
| 2022 Q1 | 369.5 Million EUR | 14975.48% |
| 2022 Q2 | 324.6 Million EUR | -12.15% |
| 2021 FY | 735.79 Million EUR | 40.56% |
| 2021 Q4 | 2.45 Million EUR | -98.97% |
| 2021 Q1 | 205.1 Million EUR | 14.63% |
| 2021 Q2 | 230.3 Million EUR | 12.29% |
| 2021 Q3 | 237.4 Million EUR | 3.08% |
| 2020 Q3 | 143.6 Million EUR | 44.47% |
| 2020 Q1 | 89.9 Million EUR | -5.96% |
| 2020 Q4 | 178.92 Million EUR | 24.6% |
| 2020 FY | 523.47 Million EUR | 47.06% |
| 2020 Q2 | 99.4 Million EUR | 10.57% |
| 2019 Q2 | 87 Million EUR | 9.3% |
| 2019 FY | 355.94 Million EUR | 18.4% |
| 2019 Q4 | 95.59 Million EUR | 15.32% |
| 2019 Q1 | 79.6 Million EUR | -5.6% |
| 2019 Q3 | 82.9 Million EUR | -4.71% |
| 2018 Q2 | 67.6 Million EUR | 21.15% |
| 2018 Q1 | 55.8 Million EUR | -43.84% |
| 2018 Q3 | 74 Million EUR | 9.47% |
| 2018 FY | 300.62 Million EUR | 14.32% |
| 2018 Q4 | 84.32 Million EUR | 13.95% |
| 2017 Q4 | 99.36 Million EUR | 99.92% |
| 2017 Q3 | 49.7 Million EUR | -12.65% |
| 2017 Q2 | 56.9 Million EUR | -0.18% |
| 2017 Q1 | 57 Million EUR | -28.54% |
| 2017 FY | 262.96 Million EUR | 6.17% |
| 2016 Q2 | 59.9 Million EUR | 20.04% |
| 2016 Q4 | 79.76 Million EUR | 37.53% |
| 2016 Q3 | 58 Million EUR | -3.17% |
| 2016 Q1 | 49.9 Million EUR | -23.29% |
| 2016 FY | 247.66 Million EUR | 17.02% |
| 2015 Q1 | 42.5 Million EUR | 19.56% |
| 2015 Q4 | 65.05 Million EUR | 16.37% |
| 2015 Q3 | 55.9 Million EUR | 15.73% |
| 2015 Q2 | 48.3 Million EUR | 13.65% |
| 2015 FY | 211.65 Million EUR | 62.63% |
| 2014 FY | 130.14 Million EUR | 4.72% |
| 2014 Q3 | 34.9 Million EUR | 3.87% |
| 2014 Q1 | 26.1 Million EUR | -31.27% |
| 2014 Q2 | 33.6 Million EUR | 28.74% |
| 2014 Q4 | 35.54 Million EUR | 1.85% |
| 2013 Q3 | 27.2 Million EUR | -13.65% |
| 2013 Q4 | 37.97 Million EUR | 39.62% |
| 2013 Q2 | 31.5 Million EUR | 14.13% |
| 2013 Q1 | 27.6 Million EUR | -36.22% |
| 2013 FY | 124.27 Million EUR | -0.95% |
| 2012 Q2 | 26.7 Million EUR | 8.98% |
| 2012 Q1 | 24.5 Million EUR | -2.97% |
| 2012 FY | 125.47 Million EUR | 34.7% |
| 2012 Q4 | 43.27 Million EUR | 39.14% |
| 2012 Q3 | 31.1 Million EUR | 16.48% |
| 2011 Q1 | 21.3 Million EUR | -18.96% |
| 2011 Q3 | 27.4 Million EUR | 41.97% |
| 2011 Q4 | 25.24 Million EUR | -7.85% |
| 2011 Q2 | 19.3 Million EUR | -9.39% |
| 2011 FY | 93.14 Million EUR | 20.84% |
| 2010 FY | 77.08 Million EUR | 222.72% |
| 2010 Q2 | 17.2 Million EUR | 25.55% |
| 2010 Q4 | 26.28 Million EUR | 35.48% |
| 2010 Q1 | 13.7 Million EUR | 37.19% |
| 2010 Q3 | 19.4 Million EUR | 12.79% |
| 2009 Q1 | 8.3 Million EUR | 0.0% |
| 2009 Q4 | 9.98 Million EUR | 10.96% |
| 2009 Q3 | 9 Million EUR | 364.71% |
| 2009 Q2 | -3.4 Million EUR | -140.96% |
| 2009 FY | 23.88 Million EUR | -57.97% |
| 2008 FY | 56.83 Million EUR | 15.21% |
| 2007 FY | 49.33 Million EUR | -8.9% |
| 2006 FY | 54.15 Million EUR | 24.06% |
| 2005 FY | 43.65 Million EUR | 34.28% |
| 2004 FY | 32.5 Million EUR | 121.47% |
| 2003 FY | 14.67 Million EUR | 8.56% |
| 2002 FY | 13.52 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 192.38 Million EUR | -182.353% |
| Carl Zeiss Meditec AG | 327.13 Million EUR | -66.047% |
| Fielmann Aktiengesellschaft | 286.54 Million EUR | -89.568% |
| Gerresheimer AG | 213.39 Million EUR | -154.556% |
| Sartorius Aktiengesellschaft | 543.2 Million EUR | 0.0% |